Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Cook

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 6, 2014
Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapyLars Hansen, Nayyar Iqbal, Ella Ekholm, et al.
Postgraduate Medicine|June 11, 2013
Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trialsWilliam Cook, Brian Bryzinski, Jill Slater, et al.
Bioinformatics (Oxford, England)|March 3, 2007
rh_tsp_map 3.0: end-to-end radiation hybrid mapping with improved speed and quality controlAlejandro A Schäffer, Edward Stallknecht Rice, William Cook, et al.
Journal of Drugs in Dermatology : JDD|September 8, 2022
Key Moments in the History of Liposuction by DermatologistsC William Hanke, Saul Asken, William Cook, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2003
Insig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytesJinping Li, Kiyosumi Takaishi, William Cook, et al.
Annals of Diagnostic Pathology|June 29, 2002
Composite mycosis fungoides and B-cell chronic lymphocytic leukemiaAndrea L Volk, Stephen A Vannucci, William Cook, et al.
Diabetes Care|October 30, 2014
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metforminJulio Rosenstock, Lars Hansen, Pamela Zee, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 23, 2023
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory BiomarkersBo Ding, Stephanie Chen, Eleni Rapsomaniki, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2017
Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical TrialsMikaela Sjöstrand, Cheryl Wei, William Cook, et al.
Journal of Asthma and Allergy|June 19, 2023
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTYBo Ding, Stephanie Chen, Divyansh Srivastava, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 6, 2014
Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapyLars Hansen, Nayyar Iqbal, Ella Ekholm, et al.
Postgraduate Medicine|June 11, 2013
Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trialsWilliam Cook, Brian Bryzinski, Jill Slater, et al.
Bioinformatics (Oxford, England)|March 3, 2007
rh_tsp_map 3.0: end-to-end radiation hybrid mapping with improved speed and quality controlAlejandro A Schäffer, Edward Stallknecht Rice, William Cook, et al.
Journal of Drugs in Dermatology : JDD|September 8, 2022
Key Moments in the History of Liposuction by DermatologistsC William Hanke, Saul Asken, William Cook, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2003
Insig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytesJinping Li, Kiyosumi Takaishi, William Cook, et al.
Annals of Diagnostic Pathology|June 29, 2002
Composite mycosis fungoides and B-cell chronic lymphocytic leukemiaAndrea L Volk, Stephen A Vannucci, William Cook, et al.
Diabetes Care|October 30, 2014
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metforminJulio Rosenstock, Lars Hansen, Pamela Zee, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 23, 2023
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory BiomarkersBo Ding, Stephanie Chen, Eleni Rapsomaniki, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2017
Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical TrialsMikaela Sjöstrand, Cheryl Wei, William Cook, et al.
Journal of Asthma and Allergy|June 19, 2023
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTYBo Ding, Stephanie Chen, Divyansh Srivastava, et al.
Pageof 3